Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$88.94

-0.24 (-0.27%)

19:05
05/23/18
05/23
19:05
05/23/18
19:05

Sarepta granted orphan status for DMD treatment golodirsen

The FDA granted Sarepta Therapeutics orphan status for golodirsen, its treatment of Duchenne muscular dystrophy. Drugs are with orphan status are entitled to seven years of market exclusivity if approved by FDA for a rare disease. Reference Link

  • 20

    Jun

SRPT Sarepta
$88.94

-0.24 (-0.27%)

05/10/18
NOMU
05/10/18
NO CHANGE
Target $131
NOMU
Buy
Nomura recommends owning Sarepta for 'second dose' of upside
An overlooked takeaway from Sarepta Therapeutics' earnings call is the company highlighting its "aggressive and ambitious" plans to progress its gene therapy program, Nomura Instinet analyst Christopher Marai tells investors in a research note. He recommends recommend owning the stock for a "second dose of potential upside." The analyst has a Buy rating on Sarepta with a $131 price target.
05/11/18
LEHM
05/11/18
UPGRADE
Target $107
LEHM
Overweight
Sarepta upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Gena Wang upgraded Sarepta Therapeutics to Overweight and raised her price target for the shares to $107 from $55. The "good safety profile" of the company's PMO franchise could replace its "suboptimal" PMO franchise, Wang tells investors in a research note. The analyst, while seeing a limited opportunity in Europe for Exondys 51, believes Sarepta's microdystrophin program has a "reasonable chance" to show promising clinical activity.
05/15/18
LEER
05/15/18
NO CHANGE
Target $121
LEER
Outperform
Sarepta price target raised to $121 from $88 at Leerink
Leerink analyst Joseph Schwartz raised his price target for Sarepta (SRPT) to $121 from $88, while reiterating an Outperform rating on the shares. The analyst notes that Sarepta is one of three companies developing microdystrophin gene therapy for Duchenne muscular dystrophy, in competition with Pfizer (PFE) who acquired Bamboo, and Solid Biosciences (SLDB). With Solid's clinical hold still in place, Sarepta could potentially be first-to-market, and is expected to report the first clinical data for a micro-dystrophin candidate at their R&D day on June 19, he adds.
05/18/18
GSCO
05/18/18
NO CHANGE
Target $127
GSCO
Buy
Sarepta price target raised to $127 from $84 at Goldman Sachs
Goldman Sachs analyst Salveen Richter raised her price target on Sarepta to $127 and kept her Buy rating, citing the company's muscular dystrophy pipeline. The analyst notes that while the launch of Exondys-51 has been successful, Sarepta's "two promising platforms" have the potential to treat the entire market. Richter states she is positive on the Nationwide Children's Hospital gene therapy program and anticipates its initial data at the company's R&D day on June 19th.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$36.25

0.3 (0.83%)

, CMCSK

Comcast

$0.00

(0.00%)

11:51
10/19/18
10/19
11:51
10/19/18
11:51
Hot Stocks
Box Office Battle: 'Halloween' opening to add to massive October »

Comcast (CMCSA, CMCSK)…

CMCSA

Comcast

$36.25

0.3 (0.83%)

CMCSK

Comcast

$0.00

(0.00%)

VIAB

Viacom

$33.63

-0.1 (-0.30%)

FOX

21st Century Fox

$45.48

0.02 (0.04%)

DIS

Disney

$118.20

1.94 (1.67%)

FOXA

21st Century Fox

$45.78

-0.03 (-0.07%)

SNE

Sony

$56.23

0.19 (0.34%)

T

AT&T

$32.77

0.27 (0.83%)

LGF.A

Lionsgate

$22.25

0.05 (0.23%)

VIA

Viacom

$37.17

-0.06 (-0.16%)

LGF.B

Lionsgate

$20.84

0.06 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

KIDS

OrthoPediatrics

$33.46

0.75 (2.29%)

11:46
10/19/18
10/19
11:46
10/19/18
11:46
Recommendations
OrthoPediatrics analyst commentary  »

FDA approval closes gap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

11:45
10/19/18
10/19
11:45
10/19/18
11:45
Hot Stocks
Breaking Hot Stocks news story  »

Mercantil Bank Holding…

11:45
10/19/18
10/19
11:45
10/19/18
11:45
General news
Breaking General news story  »

Atlanta Federal Reserve…

11:43
10/19/18
10/19
11:43
10/19/18
11:43
Conference/Events
CFTC to hold a podcast with the Federal Reserve Bank of Dallas President »

The Commodity Futures…

KIDS

OrthoPediatrics

$33.46

0.75 (2.29%)

11:41
10/19/18
10/19
11:41
10/19/18
11:41
Hot Stocks
OrthoPediatrics reports FDA 510(k) clearance for RESPONSE system »

OrthoPediatrics …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

11:40
10/19/18
10/19
11:40
10/19/18
11:40
Hot Stocks
Breaking Hot Stocks news story  »

Mercantil Bank Holding…

CTL

CenturyLink

$21.83

0.79 (3.75%)

11:40
10/19/18
10/19
11:40
10/19/18
11:40
Options
CenturyLink Inc sees increased put activity »

CenturyLink Inc sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

RHHBY

Roche

$0.00

(0.00%)

11:38
10/19/18
10/19
11:38
10/19/18
11:38
Hot Stocks
Roche reports FDA approves label update for Genentech's Rituxan »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 07

    Nov

  • 24

    Dec

HPE

HP Enterprise

$15.57

0.24 (1.57%)

11:35
10/19/18
10/19
11:35
10/19/18
11:35
Options
Hewlett Packard Enterprise put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

11:35
10/19/18
10/19
11:35
10/19/18
11:35
General news
NY Fed Q3 GDP Nowcast estimate sank to 2.13% »

NY Fed Q3 GDP Nowcast…

CLF

Cleveland-Cliffs

$10.92

-0.55 (-4.80%)

11:31
10/19/18
10/19
11:31
10/19/18
11:31
Hot Stocks
Cleveland-Cliffs CEO makes colorful comments, calls out analyst on call »

Cleveland-Cliffs CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

11:25
10/19/18
10/19
11:25
10/19/18
11:25
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

11:25
10/19/18
10/19
11:25
10/19/18
11:25
Conference/Events
RBC Capital refiners and E&P analysts to hold a luncheon meeting »

Refiners & E&P…

VLKAY

Volkswagen

$0.00

(0.00%)

11:24
10/19/18
10/19
11:24
10/19/18
11:24
Periodicals
VW starts construction on all-electric vehicle plant in China, Electrek says »

Volkswagen has begun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.59

2.26 (0.82%)

11:23
10/19/18
10/19
11:23
10/19/18
11:23
Periodicals
Mnuchin to attend Saudi anti-terror financing meeting, Washington Post says »

Treasury Secretary Steven…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.59

2.26 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLT

Hilton

$71.80

-0.28 (-0.39%)

11:20
10/19/18
10/19
11:20
10/19/18
11:20
Options
Call buyers in Hilton ahead of earnings next week »

Call buyers in Hilton…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

11:20
10/19/18
10/19
11:20
10/19/18
11:20
General news
Treasury Option Action: a round of put positioning on bonds »

Treasury Option Action: a…

APHB

AmpliPhi

$0.34

0.0142 (4.38%)

11:19
10/19/18
10/19
11:19
10/19/18
11:19
Recommendations
AmpliPhi analyst commentary  »

AmpliPhi price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCFC

United Community Financial

$9.40

0.03 (0.32%)

11:18
10/19/18
10/19
11:18
10/19/18
11:18
Hot Stocks
Breaking Hot Stocks news story on United Community Financial »

FJ Capital reports 5.03%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$61.95

-6.29 (-9.22%)

11:17
10/19/18
10/19
11:17
10/19/18
11:17
Recommendations
NuVasive analyst commentary  »

Piper remains buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 27

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/19/18
10/19
11:17
10/19/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/19/18
10/19
11:16
10/19/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.44

-0.065 (-0.76%)

, GM

General Motors

$31.17

0.09 (0.29%)

11:15
10/19/18
10/19
11:15
10/19/18
11:15
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

F

Ford

$8.44

-0.065 (-0.76%)

GM

General Motors

$31.17

0.09 (0.29%)

ROKU

Roku

$57.13

0.14 (0.25%)

DIG

The Walt Disney Internet Group

$39.45

0.28 (0.71%)

EBAY

eBay

$28.84

-2.72 (-8.62%)

PYPL

PayPal

$84.80

7.3 (9.42%)

TSLA

Tesla

$261.50

-2.35 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 07

    Nov

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

  • 13

    Dec

  • 03

    Mar

11:15
10/19/18
10/19
11:15
10/19/18
11:15
General news
Breaking General news story  »

Atlanta Federal Reserve…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.